Introduction
The incidence and prevalence of colorectal cancer in inflammatory bowel disease
Colitis-associated cancer – time for new strategies
Mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease
The data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease